Literature DB >> 25762849

Percutaneous management of chronic central venous occlusive disease.

Matthew G Gipson1, Rajan K Gupta1, Mitchell T Smith1.   

Abstract

Year:  2015        PMID： 25762849      PMCID： PMC4346044          DOI： 10.1055/s-0034-1396966

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


× No keyword cloud information.
  4 in total

Review 1.  Superior vena cava syndrome in thoracic malignancies.

Authors:  Philipp M Lepper; Sebastian R Ott; Hanno Hoppe; Christian Schumann; Uz Stammberger; Antonio Bugalho; Steffen Frese; Michael Schmücking; Norbert M Blumstein; Nicolas Diehm; Robert Bals; Jürg Hamacher
Journal:  Respir Care       Date:  2011-01-27       Impact factor: 2.258

2.  Etiologic considerations in superior vena cava syndrome.

Authors:  J M Parish; R F Marschke; D E Dines; R E Lee
Journal:  Mayo Clin Proc       Date:  1981-07       Impact factor: 7.616

Review 3.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02

4.  The superior vena cava syndrome: clinical characteristics and evolving etiology.

Authors:  Todd W Rice; R Michael Rodriguez; Richard W Light
Journal:  Medicine (Baltimore)       Date:  2006-01       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.